Edesa Biotech, Inc.
EDSA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001540159
No open-market purchases or sales by Edesa Biotech, Inc. insiders were filed in the last 90 days; 33 institutions reported holding it in 13F filings for Q2 2026, worth $30.0M in total; no superinvestor holds it.
13F holders, Q2 2025
Institutional positions in Edesa Biotech, Inc. as of Jun 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 20
- +1 vs. Q1 2025
- Shares held
- 2.11M
- −714.3K (−25.3%) vs. Q1 2025
- Total value
- $4.28M
- −$2.61M (−37.9%) vs. Q1 2025
- New holders
- 4
- 4 more added
- Sold out
- 3
- 2 more reduced
1 institution that held it in Q1 2025 haven't filed for Q2 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting EDSA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 33 | $30.0M |
| Q1 2026 | 28 | $13.8M |
| Q4 2025 | 22 | $4.34M |
| Q3 2025 | 23 | $7.10M |
| Q2 2025 | 20 | $4.28M |
| Q1 2025 | 20 | $6.89M |
| Q4 2024 | 17 | $350.1K |
| Q3 2024 | 18 | $718.2K |
| Q2 2024 | 17 | $645.1K |
| Q1 2024 | 17 | $450.9K |
| Q4 2023 | 19 | $507.1K |
| Q3 2023 | 20 | $1.26M |
| Q2 2023 | 22 | $1.63M |
| Q1 2023 | 26 | $2.05M |
| Q4 2022 | 22 | $3.53M |
| Q3 2022 | 21 | $494.2K |
| Q2 2022 | 24 | $2.26M |
| Q1 2022 | 23 | $5.51M |
| Q4 2021 | 26 | $2.03M |
| Q3 2021 | 23 | $2.85M |
| Q2 2021 | 18 | $1.37M |
| Q1 2021 | 16 | $773.7K |
Institutions, Q2 2025
Shares, value and share of portfolio for each institution holding Edesa Biotech, Inc.; share changes are against Q1 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Rubric Capital Management LP | 687,500 | $1.40M | 0.02% | 00.0% | Unchanged |
| Velan Capital Investment Management LP | 687,500 | $1.40M | 1.40% | 00.0% | Unchanged |
| Nantahala Capital Management, LLC | 625,000 | $1.27M | 0.09% | 00.0% | Unchanged |
| Commonwealth Equity Services, LLC | 35,003 | $71.0K | 0.00% | −15,000−30.0% | Reduced |
| Geode Capital Management, LLC | 27,956 | $56.5K | 0.00% | −1,014−3.5% | Reduced |
| Citadel Advisors LLC | 23,514 | $47.5K | 0.00% | +6,923+41.7% | Added |
| Vanguard Group Inc | 15,864 | $32.0K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 2,343 | $4.76K | 0.00% | +1,151+96.6% | Added |
| Royal Bank of Canada | 1,816 | $4.00K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 683 | $1.39K | 0.00% | +679+16,975.0% | Added |
| Morgan Stanley | 584 | $1.19K | 0.00% | +584 | New |
| TD Waterhouse Canada Inc. | 142 | $288 | 0.00% | 00.0% | Unchanged |
| Fifth Third Bancorp | 100 | $203 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 54 | $109 | 0.00% | +32+145.5% | Added |
| Raymond James Financial Inc | 29 | $59 | 0.00% | +29 | New |
| Global Retirement Partners, LLC | 25 | $51 | 0.00% | +25 | New |
| Danske Bank A/S | 1 | $2 | 0.00% | 00.0% | Unchanged |
| AllSquare Wealth Management LLC | 1 | $2 | 0.00% | 00.0% | Unchanged |
| Dogwood Wealth Management LLC | 1 | $2 | 0.00% | 00.0% | Unchanged |
| LRI Investments, LLC | 1 | $2 | 0.00% | +1 | New |
| Stonepine Capital Management, LLC | 0 | $0 | 0.00% | −687,500−100.0% | Sold out |
| CIBC World Markets Inc. | 0 | $0 | 0.00% | −19,999−100.0% | Sold out |
| Avion Wealth | 0 | $0 | 0.00% | −242−100.0% | Sold out |
| Credit Agricole S A | – | – | – | – | Not filed |